Ineffective Over-the-Counter Nasal Decongestants – Class Action Investigation
Chimicles Schwartz Kriner & Donaldson-Smith is investigating a potential class action related to recent studies finding that certain over-the-counter nasal decongestants are ineffective. Specifically, the FDA advisory committee unanimously agreed that oral formulations of phenylephrine, a key ingredient in many over-the-counter cold and allergy medicines, are ineffective in treating nasal decongestant. This ingredient is found in some of the most popular over-the-counter medications including Benadryl Allergy Plus Decongestant, Sudafed PE, Mucinex Sinus Max, Tylenol Cold & Flu Severe, NyQuil Severe Cold & Flu, and Theraflu Severe Cold Relief.
If you purchased a nasal decongestant containing phenylephrine, please fill-out the form provided below.
(*) Indicates required field: When communicating with us through this site or otherwise in connection with a matter for which we do not already represent you, your communication may not be treated as privileged or confidential, and does not create an attorney-client relationship between you and our Firm.
Attorneys for this case:
Steve A. Schwartz
Timothy N. Mathews